JUN and pulmonary fibrosis: In summary, these studies have provided mechanistic insights into SARS-CoV-2-induced pulmonary fibrosis, revealing critical roles for the IFN-γ, IL-6/JUN/CD47, and TGF-β pathways, as well as identifying promising therapeutic targets, such as cytokine blockade, for treating PC19-PF.